Primary prevention of severe lower respiratory illnesses in at-risk infants using the immunomodulator OM85

Severe lower respiratory illnesses (sLRI) during infancy increase the risk of asthma. The immunomodulator BronchVaxom® can increase the time to the first sLRI and reduce the cumulative burden of sLRI in "at risk" infants.